Cargando…

Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?

Detalles Bibliográficos
Autor principal:	Wei, Shu Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association for the Study of Intestinal Diseases 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083256/ https://www.ncbi.nlm.nih.gov/pubmed/27799878 http://dx.doi.org/10.5217/ir.2016.14.4.293

Ejemplares similares

Fecal calprotectin in inflammatory bowel disease
por: Walsham, Natalie E, et al.
Publicado: (2016)

The Role of Fecal Calprotectin in Investigating Inflammatory Bowel Diseases
por: Erbayrak, Mustafa, et al.
Publicado: (2009)

Fecal Calprotectin for the Diagnosis and Management of Inflammatory Bowel Diseases
por: Kapel, Nathalie, et al.
Publicado: (2023)

The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity
por: Lee, Yang Woon, et al.
Publicado: (2019)

Home-based fecal calprotectin test is expected to play an important role in patients with inflammatory bowel diseases
por: Kim, Young-Ho
Publicado: (2018)

Fecal calprotectin in daily practice for patients with inflammatory bowel disease: where do we stand in Korea?
por: Cha, Jae Myung
Publicado: (2019)

Optimal Cutoff Level of Fecal Calprotectin for Detecting Small Bowel Inflammation in Crohn’s Disease
por: Kim, Eun Soo
Publicado: (2021)

Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring
por: Wei, Shu-Chen, et al.
Publicado: (2018)

FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease
por: Rosenfeld, Greg, et al.
Publicado: (2016)

The comparison of the three assays for determination of fecal calprotectin in inflammatory bowel disease
por: Osredkar, Joško, et al.
Publicado: (2021)

Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
por: Cao, Ying, et al.
Publicado: (2021)

Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
por: Kato, Jun, et al.
Publicado: (2016)

A98 FECAL LEUKOCYTE ESTERASE: AN ALTERNATIVE BIOMARKER TO FECAL CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE
por: Klemm, N K, et al.
Publicado: (2022)

Accuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease
por: Jang, Hui Won, et al.
Publicado: (2016)

Impact of Fecal Calprotectin Measurement on Decision-making in Children with Inflammatory Bowel Disease
por: El-Matary, Wael, et al.
Publicado: (2017)

From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting
por: Mumolo, Maria Gloria, et al.
Publicado: (2018)

Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization
por: Fukunaga, Shuhei, et al.
Publicado: (2018)

Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease
por: Kittanakom, Saranya, et al.
Publicado: (2017)

Association of Fecal Calprotectin With Endoscopic and Histologic Activity in Pediatric Inflammatory Bowel Disease
por: Crawford, Erin, et al.
Publicado: (2021)

Enteric Dysbiosis and Fecal Calprotectin Expression in Premature Infants
por: Ho, Thao T. B., et al.
Publicado: (2018)

Correlation of rapid point-of-care vs send-out fecal calprotectin monitoring in pediatric inflammatory bowel disease
por: Rodriguez, Alexis, et al.
Publicado: (2017)

A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease
por: Gacesa, R., et al.
Publicado: (2021)

Calprotectin in inflammatory bowel disease
por: Khaki-Khatibi, Fatemeh, et al.
Publicado: (2020)

The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease
por: Abej, Esmail, et al.
Publicado: (2016)

A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis
por: Klingberg, Eva, et al.
Publicado: (2017)

Commentary: Impact of Fecal Calprotectin Measurement on Decision-Making in Children with Inflammatory Bowel Disease
por: Day, Andrew S., et al.
Publicado: (2017)

Fecal Calprotectin in Combination With Standard Blood Tests in the Diagnosis of Inflammatory Bowel Disease in Children
por: Ho, Shaun S. C., et al.
Publicado: (2021)

International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases
por: D'Amico, Ferdinando, et al.
Publicado: (2021)

Patient knowledge of fecal calprotectin in inflammatory bowel disease (IBD): An observational study in Mexico
por: Maldonado-Arriaga, Brenda, et al.
Publicado: (2021)

A37 FECAL CALPROTECTIN IN A PEDIATRIC, POPULATION-BASED STUDY: UTILITY IN DIAGNOSIS AND INFLAMMATORY BOWEL DISEASE MONITORING
por: Smyth, M, et al.
Publicado: (2023)

Fecal calprotectin is a useful marker to diagnose ulcerative colitis from irritable bowel syndrome
por: Kalantari, Hamid, et al.
Publicado: (2015)

Fecal Immunochemical Test and Fecal Calprotectin Measurement Are Noninvasive Monitoring Tools for Predicting Endoscopic Activity in Patients with Ulcerative Colitis
por: Chang, Ji Young, et al.
Publicado: (2018)

Diagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinic
por: Moein, Soheila, et al.
Publicado: (2017)

Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis
por: Shi, Jin-Tong, et al.
Publicado: (2023)

Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activity
por: Zittan, Eran, et al.
Publicado: (2018)

Serum Free Thiols Are Superior to Fecal Calprotectin in Reflecting Endoscopic Disease Activity in Inflammatory Bowel Disease
por: Bourgonje, Arno R., et al.
Publicado: (2019)

Fecal Calprotectin for Small Bowel Crohn’s Disease: Is It a Cutoff Issue?
por: Romero-Mascarell, Cristina, et al.
Publicado: (2022)

Clinical utility of fecal calprotectin: potential applications beyond inflammatory bowel disease for the primary care physician
por: Mari, Amir, et al.
Publicado: (2019)

Fecal Zonulin as a Noninvasive Biomarker of Intestinal Permeability in Pediatric Patients with Inflammatory Bowel Diseases—Correlation with Disease Activity and Fecal Calprotectin
por: Szymanska, Edyta, et al.
Publicado: (2021)

Time-to-reach Target Calprotectin Level in Newly Diagnosed Patients With Inflammatory Bowel Disease
por: Haisma, Sjoukje-Marije, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e99v8qsgrkhm8kao9kuseahie7